+データを開く
-基本情報
登録情報 | データベース: PDB / ID: 7ss8 | ||||||
---|---|---|---|---|---|---|---|
タイトル | Human P300 complexed with a proline-based inhibitor | ||||||
要素 | Histone acetyltransferase p300 | ||||||
キーワード | TRANSFERASE/INHIBITOR / Histone acetyltransferase / TRANSFERASE / TRANSFERASE-INHIBITOR complex | ||||||
機能・相同性 | 機能・相同性情報 behavioral defense response / peptidyl-lysine propionylation / histone lactyltransferase (CoA-dependent) activity / peptidyl-lysine crotonylation / peptidyl-lysine butyrylation / histone butyryltransferase activity / histone H3K122 acetyltransferase activity / swimming / peptide butyryltransferase activity / thigmotaxis ...behavioral defense response / peptidyl-lysine propionylation / histone lactyltransferase (CoA-dependent) activity / peptidyl-lysine crotonylation / peptidyl-lysine butyrylation / histone butyryltransferase activity / histone H3K122 acetyltransferase activity / swimming / peptide butyryltransferase activity / thigmotaxis / histone H2B acetyltransferase activity / peptide 2-hydroxyisobutyryltransferase activity / histone crotonyltransferase activity / protein propionyltransferase activity / NOTCH2 intracellular domain regulates transcription / peptidyl-lysine acetylation / lysine N-acetyltransferase activity, acting on acetyl phosphate as donor / histone H4 acetyltransferase activity / internal peptidyl-lysine acetylation / cellular response to L-leucine / histone H3 acetyltransferase activity / NFE2L2 regulating ER-stress associated genes / peptide N-acetyltransferase activity / acetylation-dependent protein binding / Activation of the TFAP2 (AP-2) family of transcription factors / NFE2L2 regulating inflammation associated genes / NGF-stimulated transcription / STAT3 nuclear events downstream of ALK signaling / histone H3K18 acetyltransferase activity / N-terminal peptidyl-lysine acetylation / histone H3K27 acetyltransferase activity / LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production / NFE2L2 regulates pentose phosphate pathway genes / TGFBR3 expression / NFE2L2 regulating MDR associated enzymes / Polo-like kinase mediated events / regulation of androgen receptor signaling pathway / regulation of mitochondrion organization / positive regulation by host of viral transcription / Regulation of FOXO transcriptional activity by acetylation / face morphogenesis / Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells / regulation of glycolytic process / RUNX3 regulates NOTCH signaling / Regulation of gene expression by Hypoxia-inducible Factor / Nuclear events mediated by NFE2L2 / NOTCH4 Intracellular Domain Regulates Transcription / FOXO-mediated transcription of cell death genes / Regulation of NFE2L2 gene expression / NOTCH3 Intracellular Domain Regulates Transcription / platelet formation / TRAF6 mediated IRF7 activation / NFE2L2 regulating anti-oxidant/detoxification enzymes / peptide-lysine-N-acetyltransferase activity / megakaryocyte development / NFE2L2 regulating tumorigenic genes / macrophage derived foam cell differentiation / regulation of tubulin deacetylation / nuclear androgen receptor binding / STAT family protein binding / protein acetylation / acyltransferase activity / internal protein amino acid acetylation / fat cell differentiation / positive regulation of transforming growth factor beta receptor signaling pathway / Formation of paraxial mesoderm / stimulatory C-type lectin receptor signaling pathway / RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known / PI5P Regulates TP53 Acetylation / acetyltransferase activity / Zygotic genome activation (ZGA) / RUNX3 regulates p14-ARF / NF-kappaB binding / histone acetyltransferase complex / Attenuation phase / intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator / somitogenesis / negative regulation of protein-containing complex assembly / negative regulation of gluconeogenesis / cellular response to nutrient levels / canonical NF-kappaB signal transduction / positive regulation of T-helper 17 cell lineage commitment / pre-mRNA intronic binding / SARS-CoV-1 targets host intracellular signalling and regulatory pathways / histone acetyltransferase activity / regulation of cellular response to heat / histone acetyltransferase / skeletal muscle tissue development / NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux / Regulation of TP53 Activity through Acetylation / 転移酵素; アシル基を移すもの; アミノアシル基以外のアシル基を移すもの / RORA activates gene expression / positive regulation of TORC1 signaling / CD209 (DC-SIGN) signaling / B cell differentiation / negative regulation of autophagy / transcription initiation-coupled chromatin remodeling / TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest / SUMOylation of transcription cofactors / regulation of signal transduction by p53 class mediator 類似検索 - 分子機能 | ||||||
生物種 | Homo sapiens (ヒト) | ||||||
手法 | X線回折 / シンクロトロン / 分子置換 / 解像度: 2.15 Å | ||||||
データ登録者 | Shewchuk, L.M. / Reid, R.A. | ||||||
資金援助 | 米国, 1件
| ||||||
引用 | ジャーナル: J.Med.Chem. / 年: 2022 タイトル: Discovery of Proline-Based p300/CBP Inhibitors Using DNA-Encoded Library Technology in Combination with High-Throughput Screening. 著者: Tian, X. / Suarez, D. / Thomson, D. / Li, W. / King, E.A. / LaFrance, L. / Boehm, J. / Barton, L. / Di Marco, C. / Martyr, C. / Thalji, R. / Medina, J. / Knight, S. / Heerding, D. / Gao, E. / ...著者: Tian, X. / Suarez, D. / Thomson, D. / Li, W. / King, E.A. / LaFrance, L. / Boehm, J. / Barton, L. / Di Marco, C. / Martyr, C. / Thalji, R. / Medina, J. / Knight, S. / Heerding, D. / Gao, E. / Nartey, E. / Cecconie, T. / Nixon, C. / Zhang, G. / Berrodin, T.J. / Phelps, C. / Patel, A. / Bai, X. / Lind, K. / Prabhu, N. / Messer, J. / Zhu, Z. / Shewchuk, L. / Reid, R. / Graves, A.P. / McHugh, C. / Mangatt, B. | ||||||
履歴 |
|
-構造の表示
構造ビューア | 分子: MolmilJmol/JSmol |
---|
-ダウンロードとリンク
-ダウンロード
PDBx/mmCIF形式 | 7ss8.cif.gz | 217.9 KB | 表示 | PDBx/mmCIF形式 |
---|---|---|---|---|
PDB形式 | pdb7ss8.ent.gz | 168.6 KB | 表示 | PDB形式 |
PDBx/mmJSON形式 | 7ss8.json.gz | ツリー表示 | PDBx/mmJSON形式 | |
その他 | その他のダウンロード |
-検証レポート
文書・要旨 | 7ss8_validation.pdf.gz | 732.1 KB | 表示 | wwPDB検証レポート |
---|---|---|---|---|
文書・詳細版 | 7ss8_full_validation.pdf.gz | 737.6 KB | 表示 | |
XML形式データ | 7ss8_validation.xml.gz | 20.9 KB | 表示 | |
CIF形式データ | 7ss8_validation.cif.gz | 30.5 KB | 表示 | |
アーカイブディレクトリ | https://data.pdbj.org/pub/pdb/validation_reports/ss/7ss8 ftp://data.pdbj.org/pub/pdb/validation_reports/ss/7ss8 | HTTPS FTP |
-関連構造データ
関連構造データ | 7sskC 7szqC 4bhwS S: 精密化の開始モデル C: 同じ文献を引用 (文献) |
---|---|
類似構造データ | 類似検索 - 機能・相同性F&H 検索 |
-リンク
-集合体
登録構造単位 |
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 |
| ||||||||
単位格子 |
|
-要素
#1: タンパク質 | 分子量: 66193.375 Da / 分子数: 1 / 変異: Y1467F, residues 1520-1581 replaced with SGGSG / 由来タイプ: 組換発現 詳細: Expressed as a GST fusion protein with a TEV cleavage site. The GST tag was removed prior to crystallization 由来: (組換発現) Homo sapiens (ヒト) / 遺伝子: EP300, P300 / プラスミド: pFastbac 発現宿主: Spodoptera frugiperda (ツマジロクサヨトウ) 参照: UniProt: Q09472, histone acetyltransferase, 転移酵素; アシル基を移すもの; アミノアシル基以外のアシル基を移すもの | ||||||||
---|---|---|---|---|---|---|---|---|---|
#2: 化合物 | #3: 化合物 | #4: 化合物 | ChemComp-C0C / | #5: 水 | ChemComp-HOH / | 研究の焦点であるリガンドがあるか | Y | |
-実験情報
-実験
実験 | 手法: X線回折 / 使用した結晶の数: 1 |
---|
-試料調製
結晶 | マシュー密度: 2.58 Å3/Da / 溶媒含有率: 52.34 % |
---|---|
結晶化 | 温度: 277 K / 手法: 蒸気拡散法 / pH: 6.5 / 詳細: 20% PEG3350, 0.1 M MES pH 6.5 |
-データ収集
回折 | 平均測定温度: 93 K / Serial crystal experiment: N | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
放射光源 | 由来: シンクロトロン / サイト: APS / ビームライン: 22-ID / 波長: 1 Å | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
検出器 | タイプ: DECTRIS EIGER X 16M / 検出器: PIXEL / 日付: 2018年6月6日 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
放射 | プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
放射波長 | 波長: 1 Å / 相対比: 1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
反射 | 解像度: 2.05→50 Å / Num. obs: 41313 / % possible obs: 96.2 % / 冗長度: 3 % / Rmerge(I) obs: 0.066 / Rpim(I) all: 0.044 / Rrim(I) all: 0.08 / Χ2: 0.775 / Net I/σ(I): 10.7 / Num. measured all: 124653 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
反射 シェル | Diffraction-ID: 1
|
-解析
ソフトウェア |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 構造決定の手法: 分子置換 開始モデル: 4bhw 解像度: 2.15→38.81 Å / Cor.coef. Fo:Fc: 0.933 / Cor.coef. Fo:Fc free: 0.921 / SU B: 9.15 / SU ML: 0.123 / 交差検証法: THROUGHOUT / σ(F): 0 / ESU R: 0.218 / ESU R Free: 0.179 / 立体化学のターゲット値: MAXIMUM LIKELIHOOD 詳細: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS U VALUES : WITH TLS ADDED
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
溶媒の処理 | イオンプローブ半径: 0.8 Å / 減衰半径: 0.8 Å / VDWプローブ半径: 1.2 Å / 溶媒モデル: MASK | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
原子変位パラメータ | Biso max: 142.71 Å2 / Biso mean: 39.67 Å2 / Biso min: 11.28 Å2
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化ステップ | サイクル: final / 解像度: 2.15→38.81 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LS精密化 シェル | 解像度: 2.15→2.206 Å / Rfactor Rfree error: 0 / Total num. of bins used: 20
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化 TLS | 手法: refined / Origin x: -2.925 Å / Origin y: 0.003 Å / Origin z: 25.275 Å
|